Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Lipocine Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −1 vs. Q4 2023
- Shares held
- 473.9K
- −10.0K (−2.1%) vs. Q4 2023
- Total value
- $2.46M
- +$1.12M (+83.1%) vs. Q4 2023
- New holders
- 2
- 4 more added
- Sold out
- 3
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 221,459 | $1.15M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 74,522 | $387.5K | 0.00% | −324−0.4% | Reduced |
| Susquehanna International Group, LLP | 59,667 | $310.3K | 0.00% | +3,066+5.4% | Added |
| Geode Capital Management, LLC | 48,854 | $254.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 25,722 | $133.8K | 0.00% | −500−1.9% | Reduced |
| Renaissance Technologies LLC | 21,097 | $110.0K | 0.00% | +2,300+12.2% | Added |
| State Street Corp | 18,626 | $96.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,014 | $10.5K | 0.00% | −224−10.0% | Reduced |
| Morgan Stanley | 722 | $3.75K | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 471 | $2.45K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 431 | $2.24K | 0.00% | +431 | New |
| Advisor Group Holdings, Inc. | 68 | $352 | 0.00% | 00.0% | Unchanged |
| Tidemark, LLC | 59 | $307 | 0.00% | 00.0% | Unchanged |
| Old Point Trust & Financial Services N A | 59 | $307 | 0.00% | +59 | New |
| Wells Fargo & Company | 42 | $218 | 0.00% | +1+2.4% | Added |
| Group One Trading, L.P. | 40 | $208 | 0.00% | −12−23.1% | Reduced |
| JPMorgan Chase & Co | 12 | $62 | 0.00% | +3+33.3% | Added |
| Royal Bank of Canada | 14 | $0 | 0.00% | −77−84.6% | Reduced |
| Wealth Effects LLC | 0 | $0 | 0.00% | −14,639−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −6−100.0% | Sold out |